The American Lung Association reports more than 150,000 people are hospitalized with pneumonia each year, leading to roughly ...

Add Yahoo as a preferred source to see more of our stories on Google. Apr. 9—(StatePoint) Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks ...

Five months ago, Merck & Co. revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar 20. Now, the company is ...

One of Merck’s next-generation pneumococcal vaccines has sailed through a mid-stage trial and is being readied for a phase 3 study next month. V116—one of three pneumococcal vaccines in Merck’s ...

U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause pneumonia and other dangerous illnesses. The recommendation was made by a scientific ...

Antimicrobial resistance and serotypes in Streptococcus pneumoniae have been evolving with the widespread use of antibiotics and the introduction of pneumococcal conjugate vaccines (PCV). Particularly ...

The CDC's Advisory Committee on Immunization Practices (ACIP) on Wednesday endorsed additional doses of COVID vaccine for high-risk groups and recommended lowering the age for adult pneumococcal ...

Pneumococcal vaccines sales are dominated by Pfizer, and to a lesser extent, Merck, each company stepping up the competition with recent FDA approvals of shots that offer broader protection. GSK wants ...

† Data calculated by present authors; not reported in the original article. COAD: Chronic obstructive airway disease; COPD: Chronic obstructive pulmonary disease; ICD: International Classification of ...